Efficacy of Risankizumab Dose Escalation Among Patients With Inflammatory Bowel Disease

Lay Summary In this study, we assessed the safety and effectiveness of risankizumab dose escalation in patients with incomplete response to standard dosing. We found that dose escalation was well tolerated and associated with lower rates of corticosteroid usage and few adverse events.